Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines
/in Colorectal Cancer, Hyperthermia, International Publications /von 2017-03-22 / Exp. Cell Res. 2017 05;354(2):112-121Current status of clinical trials assessing oncolytic virus therapy for urological cancers
/in Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial Carcinoma /von 2017-03-21 / Int. J. Urol. 2017 05;24(5):342-351Optimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model
/in Breast Cancer, Hyperthermia, International Publications /von 2017-03-13 / Sci Rep 2017 03;7:43961Immune and viral therapies for malignant primary brain tumors
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2017-03-05 / Expert Opin Biol Ther 2017 04;17(4):457-474Exosomes: From Garbage Bins to Promising Therapeutic Targets
/in Exosome, International Publications /von 2017-03-02 / Int J Mol Sci 2017 Mar;18(3)A comprehensive review of immunotherapies in prostate cancer
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2017-03-02 / Crit. Rev. Oncol. Hematol. 2017 May;113:292-303IOZK Artikel im Austin Oncology Case Reports über Krebsimpfstoffe
/in IOZK In der Presse, IOZK Veröffentlichungen /von IOZKImmunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2017-03-01 / Immunotherapy 2017 03;9(4):319-329
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de